Category: Corporate

24 March 2021

STAR Conference Spring Edition 2021: PharmaNutra meets investors following its first STAR year

The 2021 STAR Conference organised by Borsa Italiana is an opportunity to meet MTA investors following publication of the 2020 […]

15 March 2021

Pisa University and PharmaNutra working together on the Marketing Project Work education plan

The “Marketing Project Work” education plan, which challenged Pisa University students for the launch of a new PharmaNutra product, recently […]

09 February 2021

SiderAL® Forte 20 capsules confirmed the best-selling food supplement in Italy

2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. December’s market data*, […]

05 February 2021

Midcap analysis: PharmaNutra stronger than its peers. Assigned a buy rating with TP at 42 euro.

On 5ᵗʰ February, Midcap produced the “Small Touch” survey highlighting how PharmaNutra is performing more consistently that its peers. As […]

20 January 2021

PharmaNutra participates in the Italian Mid Cap Conference 2021

The third edition of the Italian Mid Cap Conference, organised by Mediobanca officially opened yesterday, seeing the participation of top […]

22 December 2020

Cetilar® Patch and Cetilar® Tape classified as Class 2A MD

The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […]

15 December 2020

PharmaNutra enters the MTA market – STAR segment of Borsa Italiana

This morning saw the floating of shares in PharmaNutra S.p.A. on the MTA market – STAR segment of the Borsa […]

01 December 2020

Partnership with the Zambon Group for the distribution of Sucrosomial® Iron in Brazil

PharmaNutra and Zambon extend their collaboration to introduce two new Sucrosomial® Iron-based products to the Brazilian market. After the […]

18 November 2020

New international distribution agreement for Greece, Cyprus and Mauritius

The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]

11 November 2020

Registration of Cetilar® and SiderAL® trademarks granted in the USA

The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]

09 November 2020

Consolidated financial report as at 30th September 2020

PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]

04 November 2020

The campaign restarts for ApportAL® “Get ready!”

PharmaNutra launches a new TV, radio and digital campaign dedicated to the nutrition supplement ApportAL®. ApportAL®, the innovative nutritional supplement […]

03 November 2020

Launch Cetilar® Tape with menthol: the new Cetilar® line product

Innovative, versatile and easy to apply – available in pharmacies from today – it’s an expansion to the patented Cetylated […]

14 September 2020

PharmaNutra consolidated interim report on 30th June 2020

PharmaNutra S.p.A. informs that the Board of Directors has examined and approved the consolidated interim report on 30th June 2020, […]

10 September 2020

New distribution agreement signed for Bolivia

The PharmaNutra Group further strengthens its presence outside Europe thanks to a new trade agreement with the Bolivian pharmaceutical company […]

08 September 2020

The Sinergie-SIMA 2020 Conference: PharmaNutra a Main Partner

Businesses and universities unite at the Sinergie-SIMA 2020 Conference in an effort to promote change and discuss present and future […]

27 August 2020

The Group keeps on growing, unlike the Italian market

The IQVIA figures for the first half of 2020 confirm the stability of PharmaNutra leadership in the nutritional supplements sector. […]

20 July 2020

PharmaNutra: 3 years since being listed on the Market

After three years since being listed on the AIM Italia Market, PharmaNutra takes stock of the situation: from the industrial […]

14 July 2020

PharmaNutra Group: revenue increases +17% in the first half of 2020

PharmaNutra also climbs the annual IQVIA ranking in number of products sold, coming twelfth out of more than 1700 Italian […]

13 July 2020

Further Analysis of PharmaNutra in Market Insight

Market Insight continues its in-depth study of PharmaNutra S.p.A. through interviews with Chairman and CEO, Roberto Lacorte, and Managing Director, […]

25 May 2020

PharmaNutra takes part int the Aim Italia Conference 2020

Great investor interest in the Company’s strategies during the virtual edition of the conference organised today by the Italian Stock […]

< 1 2 3 … 7 >